Intrinsic Value of S&P & Nasdaq Contact Us

Vincerx Pharma, Inc. VINCU NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
30/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — VINCU

Vincerx Pharma, Inc. (VINCU) and trades at $27.00. The 52-week range is 19.26-31.0.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.7, Earnings Per Share (EPS) of $-15.85.

The stock has a beta of 1.27, operates in the Healthcare sector.

Trading Data
Current Price$27.00
52-Week Range19.26-31.0
Volume30
Avg Volume (30D)560
Beta (1Y)1.27
Company
IPO Date2020-12-29
Employees42
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
CUSIP92731L205
Income (Latest Year)
EBITDA$-31.46M
Operating Income$-31.46M
Net Income$-30.07M
EPS$-15.85
EPS Diluted$-15.85
Shares Outstanding$1.9M
Balance Sheet (Latest Year)
Total Assets$8.01M
Current Assets$6.41M
Cash & ST Investments$4.99M
Total Liabilities$5.28M
Net Debt$-4.99M
Total Equity$2.72M
Valuation Ratios
P/E Ratio-1.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message